Nektar Therapeutics (NKTR): Here’s What Just Happened

Nektar Therapeutics (NASDAQ:NKTR) is one of the week’s biggest winners in biotech so far, with the company soaring during the Monday session on the release of a fresh round ...

Keep Reading →